baber/WOPTO huggingface dataset:
Patent EP-4133667-A1 (EP)
Title: Systems and methods for tci state activation and codepoint to tci state mapping
Inventor: MURUGANATHAN SIVA
IPC: H04L5/00
Filed: 2021-04-09
Abstract: Systems and methods for TCI state activation and codepoint to TCI state mapping are provided. A method performed by a wireless device for activating TCI states includes one or more of: being configured to monitor a plurality of DCI formats with the TCI field for PDSCH reception; receiving a single MAC CE to activate TCI states and map activated TCI states to the TCI field codepoints of the DCI formats; and receiving separate MAC CEs to activate TCI states and map activated TCI states to the TCI field codepoints of each of the plurality of DCI formats. As such, TCI states for downlink scheduling can be more flexibly chosen for each DCI format by using separate MAC CEs. Additionally, default TCI state definitions might be provided when state activation and state to TCI field codepoint mapping to multiple DCI formats are provided by either a single or different MAC CEs.
Patent EP-4107074-A1 (EP)
Title: Dayside-only roll steering
Inventor: TURNER ANDREW E
IPC: B64G1/24
Filed: 2021-03-29
Abstract: A method of roll steering of a spacecraft to align an aspect of the spacecraft, such as the surface of solar arrays carried by the spacecraft, to the sun, is described. The roll steering occurs only when the sun is at an angle relative to the orbital plane of the spacecraft and when the spacecraft is not eclipsed by a body it is orbiting. A spacecraft may include a controller which causes an attitude control subsystem to steer the spacecraft about a roll axis to position the surface of the solar array such that an axis normal to the surface of the solar array is aligned with the direction to a sun when the sun is visible to the spacecraft, and maintain a fixed orientation of the spacecraft about the roll axis when the sun is not visible to the spacecraft.
Patent EP-4138876-A1 (EP)
Inventor: MELIEF CORNELIS JOHANNES MARIA
IPC: G01N33/68
Filed: 2021-04-23
Abstract: L'invention concerne de longs peptides immunogènes pour le traitement de maladies associées à des coronavirus du syndrome respiratoire aigu sévère, tels que le SARS-CoV-2 ou le SARS-CoV-1. L'invention concerne également des compositions immunogènes et des vaccins comprenant de longs peptides immunogènes de l'invention et une méthode de traitement thérapeutique ou de prévention de maladies associées au SARS-CoV comprenant l'administration de peptides immunogènes selon l'invention.
Patent EP-4133619-A1 (EP)
Inventor: RAGHAVAN VASANTHAN
IPC: H04B7/06
Filed: 2021-04-09
Abstract: Aspects of the present disclosure provide inter-band carrier aggregation (CA) beam training. In certain aspects, inter-band CA beam training may include performing inter-band CA beam training for a first frequency band and inter-band CA beam training for a second frequency band between one or more base stations and a user equipment simultaneously.
Patent EP-4114891-A1 (EP)
Inventor: KOTULSKI WOJCIECH
IPC: G01N21/84
Filed: 2021-03-05
Abstract: Fluorescent pigment is introduced into the plastic composition, preferably a thermoplastic, especially polyethylene or polypropylene, in the granules formation stage, in addition to possible standard components of the composite, mixed, granules are formed, and then the granules are formed into a finished building material component, and then, with the help of a known fluorimeter, the fluorescence intensity of individual parts of the surface of a plastic element is measured and the homogeneity of the material is inferred on the basis of the differences in the results of the fluorescence intensity measurements.
Patent EP-4189518-A1 (EP)
Title: Dispositif articulé
Inventor: PARK DANIEL C
IPC: H04M1/02
Filed: 2021-05-05
Abstract: La présente description concerne des dispositifs articulés, tels que des dispositifs articulés de calcul. Un exemple peut comprendre une première partie et une seconde partie qui sont fixées avec liberté de rotation à un ensemble charnière définissant un premier axe de charnière autour duquel tourne la première partie et un second axe de charnière autour duquel tourne la seconde partie. Le système peut également comprendre un premier engrenage de temporisation, associé à la première partie, et un second engrenage de temporisation, associé à la seconde partie. Le premier engrenage de temporisation peut tourner autour d'un premier axe de temporisation parallèle au premier axe de charnière et décalé par rapport à ce dernier. Le second engrenage de temporisation peut tourner autour d'un second axe de temporisation parallèle au second axe de charnière et décalé par rapport à ce dernier. Les premier et second engrenages de temporisation peuvent s'engrener directement l'un avec l'autre pour synchroniser la rotation autour du premier axe de charnière et du second axe de charnière.
Patent EP-4149457-A1 (EP)
Inventor: CHEN ZHIJIAN
IPC: A61P35/00
Filed: 2021-05-17
Abstract: The disclosure provides, among other things, methods and uses for treating a disease or disorder, particularly a cancer, in a patient, comprising conjointly administering a CTLA4 inhibitor (e.g., an anti-CTLA4 antibody) and a STING agonist to the patient, wherein the CTLA4 inhibitor is administered intratumorally to the patient. The STING agonist can be administered intratumorally, orally or systemically (e.g., intravenously, intramuscularly, or subcutaneously) to the patient.
Patent EP-4139759-A1 (EP)
Inventor: BASMACI MERT
IPC: G05B19/418
Filed: 2021-06-23
Abstract: Method for manufacturing a workpiece with a predefined sequence of machine tools by a computer-controlled manufacturing machine wherein an optimal tool configuration is determined making use of a genetic algorithm.
Patent EP-4182696-A1 (EP)
Title: Gdf-15 for predicting the disease severity of a patient with covid-19
Inventor: OMLAND TORBJOERN
IPC: G01N33/68
Filed: 2021-07-16
Abstract: The present invention relates to a method for predicting the disease severity in a patient with COVID-19, said method comprising a) determining the level of GDF-15 in a sample from the patient with COVID-19, b) comparing the level determined in step a) to a reference, and predicting the disease severity in a patient with COVID-19. Also encompassed are methods for risk stratification, monitoring of the disease progression and the risk prediction for hospital admission in a patient with COVID-19. Furthermore, methods are provided for predicting the need for intensive care, the risk for thrombosis, pulmonary embolism, hypoxia and mortality in a patient with COVID-19.
Patent EP-4181876-A1 (EP)
Inventor: CARPENTIER YVON
IPC: A61P9/10
Filed: 2021-07-13
Abstract: Isotonic lipid emulsion for use in the treatment of a number of diseases such as an acute heart ischemia, a brain ischemia or another organ damage which occurred on a day, where the treatment is applied by intravenous bolus injection which is repeated at time intervals during at least that day at which the disease occurred, the isotonic lipid emulsion comprising a 78 to 95% by weight of medium chain triglycerides and 5 to 22% by weight of a substance, said substance being either a fish oil, wherein the fish oil has an eicosapentaenoic acid content of from 20 to 50% by weight; or an eicosapentaenoic acid, or a docosapentaenoic acid, or a docosahexaenoic acid, or a combination of eicosapentaenoic acid, and/or docosapentaenoic acid, and/or docosahexaenoic acid.
Patent EP-4108711-A1 (EP)
Inventor: IMANISHI YASUYUKI
IPC: C08J5/18
Filed: 2021-02-18
Abstract: There is provided a polypropylene film that has excellent reliability and withstand voltage characteristics in high temperature environments when used in high voltage capacitors, that has a structure with excellent stability against heat and is suitable for applications in capacitors or the like to be used at high temperatures and high voltages, and that has excellent processability and does not wrinkle during a conveyance process including a vapor deposition process. 
     The present invention provides a polypropylene film in which an absolute value of a difference between a crystallite size obtained by scanning an α crystal (110) plane by wide angle X-ray diffraction in a main alignment direction and a crystallite size obtained by scanning an α crystal plane in a direction orthogonal to the main alignment direction is 3.0 nm or less, and a shrinkage stress in a machine direction (SF 135 MD) is 2.0 MPa or less at 135°C in a heating process at a temperature elevation rate of 10°C/min in thermomechanical analysis (TMA) .
Patent EP-4109700-A1 (EP)
Title: System planning assistance system and system planning assistance method
Inventor: SUENAGA SHINYA
IPC: G06Q50/06
Filed: 2021-01-20
Abstract: A power system planning support system stores first information indicating a performance of usage statuses of a plurality of electric devices that change an electric power flow of an electric power system in a predetermined period, second information indicating a performance index of the electric power system in the predetermined period, and third information indicating a change in the usage status of each of the electric devices estimated when each of the electric devices is changed, estimates, based on the first information and the third information, a usage status of each of the electric devices after being changed, estimates, based on the estimated usage status of each of the electric devices and a contribution degree to a change in the performance index of the electric power system when each of the electric devices is changed, the change in the performance index of the electric power system when each of the electric devices is changed, and outputs the estimated change in the performance index.
Patent EP-4200124-A1 (EP)
Title: Verfahren zum verbinden zweier fügeflächen
Inventor: ROUSSEL-GARCIA RAQUEL
IPC: B29C65/52
Filed: 2021-08-16
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zum Verbinden einer ersten Fügefläche eines ersten Werkstücks mit einer zweiten Fügefläche eines zweiten Werkstücks mit den Schritten: 1) Inkontaktbringen der ersten und der zweiten Fügefläche, 2) Inkontaktbringen eines ersten Werkzeugteils mit dem ersten Werkstück und Einbringen von Energie in das erste Werkstück über das erste Werkzeugteil. Um ein Verfahren anzugeben, das auch Materialien mit geringem thermoplastischem Anteil oder sogar Materialien ohne thermoplastischem Anteil verschweißen kann, ohne dass auf Klebstoffe zurückgegriffen werden muss, wird erfindungsgemäß vorgeschlagen, dass vor Schritt 1) der Schritt: A) Aufbringen von Partikeln aus thermoplastischem Material auf die erste und/oder zweite Fügefläche durchgeführt wird.
Patent EP-4164576-A1 (EP)
Title: Mechanism of an adjustable handling wheel and method of positioning thereof
Inventor: HERMAN JAKUB
IPC: A61G13/10
Filed: 2021-06-08
Abstract: A technical solution describes a mechanism of deployment and retracting an adjustable handling wheel from under different types of equipment standing on the floor, or different types of furniture such as chairs, medical chairs, nursery chairs, examination chairs (hereinafter generally as chairs), bedside tables, beds without chassis, cabinets and others. The solution presented in this patent application enables very easy handling and movement of said furniture from one place to another place using very simple mechanism of adjustable handling wheel, which is hidden in the bottom part of said equipment or furniture.
Patent EP-4099590-A1 (EP)
Title: Method for configuring spectrum resources, network device and system
Inventor: PAN DENG
IPC: H04J14/02
Filed: 2021-03-02
Abstract: This application provides a spectrum resource configuration method, a network device, and a system. The method includes: A network device determines spectrum resources to be used by a to-be-opened channel, where the spectrum resources to be used by the to-be-opened channel include first spectrum resources and a second spectrum resource, the first spectrum resources are original spectrum resources of the to-be-opened channel, the second spectrum resource is some of original spectrum resources of an adjacent channel of the to-be-opened channel, and the original spectrum resources of the adjacent channel are adjacent to the original spectrum resources of the to-be-opened channel; and opens the to-be-opened channel based on the spectrum resources to be used by the to-be-opened channel. According to the technical solutions in this application, channel damage caused by filtering costs is reduced, and service transmission performance is improved, without increasing hardware costs and software control complexity.
Patent EP-4211704-A1 (EP)
Inventor: SCOTT IAN RICHARD
IPC: G21C3/54
Filed: 2021-09-01
Abstract: A passive nuclear reactor control device. The passive nuclear reactor control device comprises a sealed chamber, which comprises a reservoir and a tube in fluid communication with the reservoir. A molten salt is within the sealed chamber, the molten salt being a eutectic mixture of a monovalent metal halide, and a fluoride or chloride of one or more lanthanides and/or a luoride or chloride of hafnium. A gas is within the sealed chamber, and the gas does not react with the molten salt.
Patent EP-4121070-A1 (EP)
Title: Méthodes de traitement du cancer par inhibition de carm1
Inventor: WUCHERPFENNIG KAI
IPC: A61K35/17
Filed: 2021-03-18
Abstract: La présente divulgation concerne une méthode de traitement d'un sujet ayant un cancer. La méthode comprend la réduction de l'expression d'un gène Carm 1 et/ou d'un gène effecteur Carm 1 dans une cellule du sujet et/ou la réduction de l'activité d'une protéine Carm 1 et/ou d'une protéine effectrice Carm 1 dans une cellule du sujet. Le cancer est résistant à l'immunothérapie et/ou au traitement de blocage de point de contrôle.
Patent EP-4047353-A1 (EP)
Inventor: FUKUURA TOMOHIRO
IPC: G01N21/64
Filed: 2021-02-24
Abstract: Provided are a metal-based particle assembly including a plurality of metal-based particles arranged apart from each other, wherein the plurality of metal-based particles are each arranged so that an average distance between metal-based particles adjacent to each other is 1 nm or more and 1000 nm or less, and a standard deviation of the average distance is 25 nm or less; a layered body including the metal-based particle assembly; and a sensing apparatus including the layered body, a capturing layer that is arranged on the metal-based particle assembly and has a capturing substance for capturing an analyte, the analyte being labeled with a luminescent substance, a light-transmitting member, a light source that emits excitation light for exciting the luminescent substance, and a detector that detects emission from the luminescent substance.
Patent EP-4217379-A1 (EP)
Title: Mage-a3 specific t cell receptors and their use
Inventor: DAVARI KATHRIN
IPC: C07K14/725
Filed: 2021-09-24
Abstract: The present invention relates to an isolated T cell receptor (TCR) specific for a MAGE-A3-derived peptide and to a polypeptide comprising a functional portion of the TCR. Further implicated are a multivalent TCR complex, a nucleic acid sequence encoding a TCR, a cell expressing the TCR and a pharmaceutical composition comprising the TCR. The invention also refers to the TCR for use as a medicament, in particular to the TCR for use in the treatment of cancer.
Patent EP-4133956-A1 (EP)
Inventor: LI JUNHUI
IPC: A24F47/00
Filed: 2021-04-12
Abstract: Disclosed are an aerosol generation apparatus and a susceptor (30), where the aerosol generation apparatus includes a cavity for receiving a smokable material (A), and the susceptor (30) at least partially extending along the axial direction of the cavity, when the smokable material (A) is received within the cavity in use, the susceptor (30) is inserted into the smokable material (A) for heating; the susceptor (30) includes an avoidance portion (32) and a heating portion (31) sequentially provided along the direction close to a proximal end (41); the size of at least a part of the avoidance portion (32) along the cross-sectional direction of the cavity is less than that of the heating portion (31), such that a certain gap is retained between the susceptor and the smokable material (A), when the susceptor (30) is inserted into the smokable material (A). When in use, a front end, inserted into the cavity, of the smokable material (A) is less heated without forming scorch or brittle slag and has a better physical form, such that when the smokable material (A) is removed from the cavity, tobacco slag falling out from the inside can be retained and blocked, reducing falling of the tobacco slag and keeping the cavity and the susceptor (30) clean.
Patent EP-4221713-A1 (EP)
Inventor: PICARD DAMIEN
IPC: A61K31/5383
Filed: 2021-09-29
Abstract: The present invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, for use in the treatment of Hereditary Hemorrhagic Telangiectasia (HHT).
Patent EP-4236913-A1 (EP)
Title: Gel et suppositoire et procédés pour fournir le gel et le suppositoire
Inventor: GORDON SPENCER
IPC: A61K9/00
Filed: 2021-09-20
Abstract: La présente invention concerne un gel et un suppositoire et un procédé pour fournir le gel et le suppositoire. Le gel comprend : entre 50 et 150 millimolaires de concentré d'acide lactique ; et entre 0,5 et 10 millimolaires de concentré de peroxyde d'hydrogène. Le suppositoire comprend : entre 22,5 et 67,5 milligrammes de concentré d'acide lactique ; et entre 1 et 20 milligrammes de concentré de peroxyde d'hydrogène.
Patent EP-4228758-A1 (EP)
Inventor: BERNARDELLI PATRICK
IPC: A61P13/08
Filed: 2021-10-19
Abstract: Disclosed herein are compounds of the formula (I), or pharmaceutically acceptable salts thereof wherein R1 and R2 represent a hydrogen atom or a deuterium atom; R3 represents a hydrogen atom, a -COOH group or a -OH group; R3' and R3" represent a hydrogen atom, a methyl group, a methoxy group, a chlorine atom, a fluorine atom, or a cyano group; R4 and R5 represent a hydrogen atom, a halogen atom, a -IMH2 group, a (C 1 - C 3 )alkyl group, a (C1-C3)alkoxy group, or a -OH group; or R4 and R5 together form an oxo group or R4 and R5 together form a =NOCH 3  group or a (C 3 -C 5 )cycloalkyl group; R7 represents a hydrogen atom, a methyl group, a -OH group or a fluorine atom; R6 represents a phenyl group, a fused phenyl group, a bicyclic group comprising 5 to 12 carbon atoms, a heteroaryl group comprising 2 to 9 carbon atoms and comprising from 1 to 3 heteroatoms, a cycloalkyl group comprising 3 to 7 carbon atoms, a (C3-C6) cycloalkyl (C1-C3) alkyl group, a 3 to 8 membered-heterocycloalkyl group, a (C1-C6)alkyl group or a phenyl (C 1 - C 2 ) alkyl group; X represents - CH 2 -, -O- or -S-; Y represents -CH=, - N= or -CR" =; R8 represents a (C 1 -C 3 ) alkyl group, a halogen atom, a cyano group, or a (C 1 -C 3 ) fluoroalkyl group; R9 represents a hydrogen atom or a fluorine atom; RIO and RIO'represent a hydrogen atom or a fluorine atom; Rll represents a hydrogen atom a (C 1 -C 3 )alkyl group or a cyclopropyl group; n is 0, 1 or 2, and m is 0 or 1. Further disclosed are process for preparing the same, pharmaceutical compositions comprising them as well as said compounds of formula (I) for use as an inhibitor and degrader of estrogen receptors, in particular in the treatment of ovulatory dysfunction, cancer, endometriosis, osteoporosis, benign prostatic hypertrophy or inflammation.
Patent EP-4233103-A1 (EP)
Inventor: BAUDRY MICHELLE
IPC: H01M4/04
Filed: 2021-10-26
Abstract: The present invention relates to an electrode comprising a current collector formed by a metal strip which is coated on at least one of the faces thereof with a composition of electrochemically active materials, the composition comprising at least one lithium manganese iron phosphate having the following formula: Li x Mn 1-y-z Fe y M z PO 4  , where M is selected from the group consisting of B, Mg, Al, Si, Ca, Ti, V, Cr, Co, Ni, Cu, Zn, Y, Zr, Nb and Mo, alone or in a mixture, with 0.8 ≤x ≤ 1.2; 0.5 ≤ 1-y-z < 1; 0.05 ≤ y ≤ 0.5 and 0 ≤ z ≤ 0.2; the current collector having undergone chemical pickling of at least one of the faces thereof.
Patent EP-4145236-A1 (EP)
Inventor: SAKAMAKI YUTA
IPC: G08C17/00
Filed: 2021-04-08
Abstract: A sensor authentication registration system includes: sensors for detecting a state quantity of a sensing target device; and setting device that stores installation information for each of the sensors. A radio wave intensity measurement unit that measures intensity of a radio wave in wireless communication is provided to at least one of the sensors or the setting device. The setting device can perform an authentication operation to store the installation information when the presence of a sensor, the installation information of which is not stored, is detected and the radio wave intensity is equal to or higher than a threshold value. A data collection system includes: sensors; and data collection device that stores installation information for each of the sensors and receives state quantities detected by the sensors via wireless communication. In the device and a method for data collection, the state quantity is automatically received when the data collection device approaches to within a range where the wireless communication with the sensor, whose installation information is stored, can be received.
Patent EP-4151081-A1 (EP)
Title: Indoor environment adjustment method and indoor environment adjustment system
Inventor: KOMABA HIROMI
IPC: A01G18/22
Filed: 2021-05-10
Abstract: Provided are an indoor environment adjustment method that contributes to stabilization of the quality of a fungal bed and an indoor environment adjustment system capable of implementing the indoor environment adjustment method. The indoor environment adjustment method of the present invention is a method of adjusting an environment in a small room (20) in which a fungal bed production device (10) is installed, and the indoor environment adjustment method includes: acquiring outdoor environment information on an outside of the small room (20); and adjusting an indoor environment inside the small room (20) based on the acquired outdoor environment information. The indoor environment adjustment system of the present invention is a system for adjusting the environment in the small room (20) in which the fungal bed production device (10) is installed, and the indoor environment adjustment system includes: indoor environment adjustment means (30) for adjusting an indoor environment inside the small room (20); outdoor information acquisition means (40) for acquiring outdoor environment information on an outside of the small room (20); and control means (50) for controlling the indoor environment adjustment means (30) based on the outdoor environment information acquired by the outdoor information acquisition means (40).
Patent EP-4214200-A1 (EP)
Title: Ligands lancl
Inventor: BASSAGANYA-RIERA JOSEP
IPC: C07D401/14
Filed: 2021-10-20
Abstract: L'invention concerne des composés qui ciblent la famille de protéines de la lanthionine synthétase de type C (LANCL), comprenant LANCL2 et LANCL3. Les composés peuvent être utilisés pour traiter des états tels que des maladies inflammatoires, des maladies métaboliques, des maladies auto-immunes, des cancers et des maladies infectieuses. Des exemples d'états comprennent des états inflammatoires du foie, tels que la stéatose hépatique non alcoolique, la stéatohépatite non alcoolique et la cirrhose ; des états inflammatoires du conduit biliaire, tels que l'angiocholite biliaire primaire, l'angiocholite sclérosante primitive ; une maladie intestinale inflammatoire, telle que la maladie de Crohn et la colite ulcéreuse ; le lupus, tel que le lupus érythémateux disséminé, la néphropathie lupique et le lupus cutané ; l'arthrite, telle que la polyarthrite rhumatoïde ; l'hyperglycémie, telle que le diabète de type 1, le diabète de type 2, et le prédiabète et des états associés tels que l'athérosclérose et une maladie rénale diabétique ; le psoriasis ; et la sclérose en plaques.